Activation of G protein-coupled receptor 40 alleviates STAT6 activation, airway inflammation and mucus hypersecretion in allergic asthma
Open Access
- 16 June 2026
- journal article
- Published by Elsevier in Current Research in Pharmacology and Drug Discovery
- Vol. 11, 100260
Abstract
No abstract availableKeywords
Funding Information
- Mahidol University
- National Research Council of Thailand (N42A680388)
This publication has 40 references indexed in Scilit:
- GPR120/FFAR4 stimulation attenuates airway remodeling and suppresses IL-4- and IL-13-induced airway epithelial injury via inhibition of STAT6 and AktBiomedicine & Pharmacotherapy, 2023
- Lactobacillus rhamnosus 76 alleviates airway inflammation in ovalbumin-allergic mice and improves mucus secretion by down-regulating STAT6/SPDEF pathwayImmunobiology, 2023
- Group 2 innate lymphoid cells in human asthmaAllergology International, 2022
- Pharmacological stimulation of G–protein coupled receptor 40 alleviates cytokine-induced epithelial barrier disruption in airway epithelial Calu-3 cellsInternational Immunopharmacology, 2019
- Anti-atherosclerotic action of GW9508 – Free fatty acid receptors activator – In apoE-knockout micePharmacological Reports, 2019
- The emergence of new biologics for severe asthmaCurrent Opinion in Pharmacology, 2019
- Linking energy sensing to suppression of JAK-STAT signalling: A potential route for repurposing AMPK activators?Pharmacological Research, 2018
- AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic BalanceMolecular Cell, 2017
- Interleukin-13 stimulates MUC5AC expression via a STAT6-TMEM16A-ERK1/2 pathway in human airway epithelial cellsInternational Immunopharmacology, 2016
- Role of omega-3 fatty acids and their metabolites in asthma and allergic diseasesAllergology International, 2015